Citadel Advisors
RBOT

Citadel Advisors’s Vicarious Surgical RBOT Stock Holding History

Citadel Advisors’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-980
Closed -$53.8K – 14964
2023
Q2 		$53.8K Sell
980
-3
-0.3% -$191 ﹤0.01% 11716
2023
Q1 		$67K Buy
+983
New +$76.4K ﹤0.01% 11795
2022
Q4 		– Sell
-1,957
Closed -$197K – 15347
2022
Q3 		$197K Sell
1,957
-2,373
-55% -$276K ﹤0.01% 10414
2022
Q2 		$382K Buy
4,330
+730
+20% +$89.2K ﹤0.01% 9241
2022
Q1 		$546K Buy
3,600
+1,023
+40% +$190K ﹤0.01% 9174
2021
Q4 		$821K Sell
2,577
-1,166
-31% -$411K ﹤0.01% 8426
2021
Q3 		$1.68M Buy
+3,743
New +$1.19M ﹤0.01% 6810

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return

Citadel Advisors's RBOT Position: Q3 2023 in Review

Citadel Advisors sold out of Vicarious Surgical (RBOT) in Q3 2023, closing a stake of 35 shares — an estimated $1.91K sold.

Citadel Advisors first reported a position in RBOT in Q4 2020 and held it in 8 quarters. The position peaked at $13M in Q2 2021. 83 funds tracked by Wall St. Rank hold RBOT as of Q3 2023.

  • Citadel Advisors reported no remaining Vicarious Surgical position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 35 Vicarious Surgical shares in Q3 2023, an estimated $1.91K.
  • Citadel Advisors first reported a position in Vicarious Surgical in Q4 2020 and held it in 8 quarters.
  • Citadel Advisors's Vicarious Surgical position peaked at $13M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.